MRVL and MBCOF Related Headlines

Go Back

Apr 23, 2026 07:30AM Marvel Biosciences to Participate and Present at the 2nd Neuroscience Innovation Partnering and Licensing Summit

Apr 16, 2026 07:00AM Marvel Biosciences Identifies Liquid Formulations for Neurodevelopmental Disorders

Apr 7, 2026 12:26PM Marvel Biosciences secures funding for autism drug trial from 5 Horizons

Apr 7, 2026 07:30AM Marvel Biosciences Secures Financial and Strategic Investment with 5 Horizon Ventures

Mar 30, 2026 07:30AM Marvel Biosciences Secures Alberta Innovates Funding to Support the Phase I Testing of MB-204

Mar 25, 2026 07:30AM Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204

MRVL and MBCOF Related Press Releases

Go Back

Apr 23, 2026 07:30AM Marvel Biosciences to Participate and Present at the 2nd Neuroscience Innovation Partnering and Licensing Summit

Apr 16, 2026 07:00AM Marvel Biosciences Identifies Liquid Formulations for Neurodevelopmental Disorders

Apr 7, 2026 07:30AM Marvel Biosciences Secures Financial and Strategic Investment with 5 Horizon Ventures

Mar 30, 2026 07:30AM Marvel Biosciences Secures Alberta Innovates Funding to Support the Phase I Testing of MB-204

Mar 25, 2026 07:30AM Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204

MRVL and MBCOF Related SEC Filings

Go Back